Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Finland Begins Large-Scale National Genomic Study

The country of Finland is conducting a nationwide genomic analysis of its population, collecting 500,000 blood samples from its 5.5 million citizens. . . . → Read More: Finland Begins Large-Scale National Genomic Study

Biotechs Partner on HPV Cancer Immunotherapies

Biotechnology companies in the U.S. and the Netherlands are collaborating on treatments for cancers caused by a type of human papillomavirus, or HPV. . . . → Read More: Biotechs Partner on HPV Cancer Immunotherapies

Tobacco Plants Studied as Drug Bio-Factories

A university in Australia is joining a European research project to create new types of tobacco plants for producing pharmaceuticals. . . . → Read More: Tobacco Plants Studied as Drug Bio-Factories

Large-Scale Genome Editing Technology in Development

Two biotechnology companies are creating an automated process for delivering large, complex genetic cargoes into cells for genome editing. . . . → Read More: Large-Scale Genome Editing Technology in Development

Genome Editing Enhances CAR T-Cells to Fight Cancer

A process using genome editing is shown to bolster cancer-fighting properties of T-cells from the immune system already modified to attack cancer cells. . . . → Read More: Genome Editing Enhances CAR T-Cells to Fight Cancer

Process Devised for Continuous Stem Cell Production

Researchers in the U.K. developed a process for closed-loop continuous production and collection of large quantities of stem cells for therapies. . . . → Read More: Process Devised for Continuous Stem Cell Production

Thin, Flexible, Lower-Cost Motion Sensors Developed

Engineers in the U.S. and France created and tested motion-detecting sensors more flexible and thinner than today’s sensors, and made with a low-cost process. . . . → Read More: Thin, Flexible, Lower-Cost Motion Sensors Developed

Sanofi Acquires Multiple Sclerosis Drug in $800M Deal

Drug maker Sanofi is licensing a drug candidate from Principia Biopharma Inc. designed to treat multiple sclerosis, an autoimmune condition affecting the brain and nervous system. . . . → Read More: Sanofi Acquires Multiple Sclerosis Drug in $800M Deal

New Drug Shown to Reduce Depressive Behaviors

A new type of treatment for depression that works differently from most other anti-depressive drugs was shown in lab mice to reduce depression-like behaviors. . . . → Read More: New Drug Shown to Reduce Depressive Behaviors

Autonomous, Human-Friendly Forklifts Being Developed

An academic-industry team in Europe is developing new forklift vehicles that can work safely alongside humans in warehouses. . . . → Read More: Autonomous, Human-Friendly Forklifts Being Developed